208 results
8-K
LUMO
Lumos Pharma Inc
5 Jun 24
Lumos Pharma Announces New Analyses of Phase 2
4:09pm
of KPMG, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
At the meeting … of KPMG, LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2024.
The final voting
8-K
EX-99.1
ezdjhw5z5clprd77
15 Nov 23
Other Events
4:38pm
8-K
EX-99.1
2lw2jol tr2p7iqhv
7 Nov 23
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
4:42pm
8-K
pimm7og3ghhlu
15 May 23
Submission of Matters to a Vote of Security Holders
4:26pm
424B5
yj8amhb6lv2gqawfog
29 Aug 22
Prospectus supplement for primary offering
5:14pm